Download presentation
Presentation is loading. Please wait.
Published byBaldwin Heath Modified over 8 years ago
1
Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs Daniel H. Solomon, MD, MPH, Joel M. Kremer, MD, Mark Fisher, MD, Jeffrey R. Curtis, MD, MPH, Victoria Furer, MD, MPH, Leslie R. Harrold, MD, MPH, Marc C. Hochberg, MD, MPH, George Reed, PhD, Peter Tsao, MSc, Jeffrey D. Greenberg, MD, MPH Seminars in Arthritis and Rheumatism Volume 43, Issue 4, Pages 489-497 (February 2014) DOI: 10.1016/j.semarthrit.2013.08.003 Copyright © 2014 Elsevier Inc. Terms and Conditions Terms and Conditions
2
Fig. 1 Seminars in Arthritis and Rheumatism 2014 43, 489-497DOI: (10.1016/j.semarthrit.2013.08.003) Copyright © 2014 Elsevier Inc. Terms and Conditions Terms and Conditions
3
Fig. 2 Seminars in Arthritis and Rheumatism 2014 43, 489-497DOI: (10.1016/j.semarthrit.2013.08.003) Copyright © 2014 Elsevier Inc. Terms and Conditions Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.